Analysis of Human Cultured Myotubes Responses Mediated by Ryanodine Receptor 1
Overview
Critical Care
Authors
Affiliations
Malignant hyperthermia is a life-threatening condition caused by autosomal dominant mutations in the ryanodine receptor type 1 gene. Identifying patients predisposed to malignant hyperthermia is done through the Ca-induced Ca release test in Japan. We examined the intracellular calcium concentration in human cultured muscle cells and compared the sensitivity of myotubes to ryanodine receptor type 1 activators based on the Ca-induced Ca release rate. We assessed the utility of this method as an identifying test for predisposition to malignant hyperthermia. Muscle specimens were obtained from 34 individuals undergoing the Ca-induced Ca release test. We cultured myotubes from residual material and monitored changes in intracellular calcium concentration after exposure to the ryanodine receptor type 1 activators caffeine, halothane and 4-chloro-m-cresol by measuring fura-2 fluorescence. We determined the half maximal effective concentrations (EC50) for the test compounds in each myotube and calculated cut-off points using receiver operating characteristic curves. Seventeen patients each were classified into the accelerated and non-accelerated groups based on their Ca-induced Ca release rate. The EC50 values for caffeine, halothane and 4-chloro-m-cresol of the accelerated group were significant lower than those of the non-accelerated group (P < 0.001, P < 0.001 and P < 0.001, respectively). The calculated cut-off points of EC50 values for caffeine, halothane and 4-CmC were 3.62 mM, 2.28 mM and 197 microM, respectively. An increased sensitivity to ryanodine receptor type 1 activators was seen in myotubes in the accelerated group. This functional test on human cultured myotubes indicates that the alteration of their intracellular Ca2+ homeostasis may identify the predisposition to malignant hyperthermia.
Miyoshi H, Otsuki S, Mukaida K, Kido K, Sumii A, Ikeda T Genes (Basel). 2023; 14(11).
PMID: 38002952 PMC: 10671487. DOI: 10.3390/genes14112009.
Figueroa L, Kraeva N, Manno C, Ibarra-Moreno C, Tammineni E, Riazi S Br J Anaesth. 2023; 131(1):47-55.
PMID: 36792386 PMC: 10308439. DOI: 10.1016/j.bja.2023.01.008.
Lawal T, Wires E, Terry N, Dowling J, Todd J Orphanet J Rare Dis. 2020; 15(1):113.
PMID: 32381029 PMC: 7204063. DOI: 10.1186/s13023-020-01384-x.
Otsuki S, Yasuda T, Mukaida K, Noda Y, Kanzaki R, Miyoshi H J Anesth. 2018; 32(4):616-623.
PMID: 29938387 DOI: 10.1007/s00540-018-2526-4.
Kondo T, Yasuda T, Mukaida K, Otsuki S, Kanzaki R, Miyoshi H J Anesth. 2018; 32(2):174-181.
PMID: 29344738 DOI: 10.1007/s00540-018-2451-6.